Logo

Efficacy of Chemiluminescence (ViziLite™) as a Screening Method in the Detection of Clinically Suspicious Oral Cancerous and Precancerous Lesions

Authors

  • Antonio Carrera Torres

    Clinical Associate in Oral Medicine, Dental School, University of Seville, Spain

  • Ángel Martínez-Sahuquillo Márquez

    Senior Clinical Lecturer in Oral Medicine, Dental School, University of Seville, Spain

  • Javier Fernández Farhall

    Clinical Lecturer of the Postgraduate Specialty in Periodontics, Department of Health Sciences II, University Rey Juan Carlos, Madrid, Spain

  • María José Cobos Fuentes

    Honorary Lecturer in Oral Medicine, Dental School, University of Seville, Spain

  • Isabel Gallardo Castillo

    Honorary Lecturer in Oral Medicine, Dental School, University of Seville, Spain

DOI:

https://doi.org/10.6000/1927-7229.2013.02.03.8

Keywords:

Chemiluminescence, screening method, oral cancer

Abstract

 Several screening techniques based on light interaction with tissue have been described to aid clinicians in the detection of early oral cancerous lesions. One of the most studied techniques is chemiluminescence. This method has been used in different studies but always by Oral Medicine specialists.

Objective: To evaluate the chemiluminescence system as a screening method in the detection of clinically suspicious cancerous and precancerous oral lesions when used by clinicians without an Oral Medicine Speciality.

Study Design: A total of 100 patients attending the Oral Medicine Unit at the Dental School of the University of Seville were enrolled. All patients were current smokers and were above the age of 40. The clinical examination was performed by dental students who were instructed in the location and recognition of potentially malignant oral disorders, using visual examination and the chemiluminescence test ViziLite Plus  (Zila Pharmaceuticals, Phoenix, AZ, USA). To assess the validity of the chemiluminescence test as a screening method, a visual exam was performed by a specialist in Oral Medicine which was used as a gold-standard.

Results: Conventional oral visual examination by the Oral Medicine Specialist found 13 lesions suspicious for malignancy, out of which 7 were also detected using the chemiluminescence test. Furthermore, 87 patients were diagnosed as lesion-free, of which 49 obtained negative results during the chemiluminescence test and 38 patients had some sort of lesion. With these results, the test yielded a sensitivity of 0.56 and a specificity of 0.56. These results indicate values similar to other studies, in fact lower sensitivity values, possibly due to the lack of experience of the clinician.

Conclusions: The chemiluminescence test (ViziLite Plus) did not present any advantages in terms of cost-benefit compared to conventional examination as a screening method for cancerous and precancerous oral lesions.

References

Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000: Cancer Incidence. Mortality and prevalence worldwide IARC CancerBase No. 5. 2001 Lyon(IARC Press).

Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 2008; 44(1): 10-22. http://dx.doi.org/10.1016/j.oraloncology.2007.06.011

Epstein JB, Zhang L, Rosin M. Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 2002; 68(10): 617-21.

Williams PM, Poh CF, Hovan AJ, Ng S, Rosin MP. Evaluation of a suspicious oral mucosal lesion. J Can Dent Assoc 2008; 74(3): 275-80.

Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 1968; 65(4): 281-93.

Ramadas K, Sankaranarayanan R, Jacob BJ, Thomas G, Somanathan T, Mahe C, et al. Interim results from a cluster randomized controlled oral cancer screening trial in kerala, india. Oral Oncol 2003; 39(6): 580-8. http://dx.doi.org/10.1016/S1368-8375(03)00041-1

Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in kerala, india: A cluster-randomised controlled trial. Lancet 2005; 365(9475): 1927-33.

http://dx.doi.org/10.1016/S0140-6736(05)66658-5

Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, et al. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess 2006; 10(14): 1,144, iii-iv.

Mignogna MD, Fedele S. Oral cancer screening: 5 minutes to save a life. Lancet 2005; 365(9475): 1905-6. http://dx.doi.org/10.1016/S0140-6736(05)66635-4

Downer MC, Jullien JA, Speight PM. An interim determination of health gain from oral cancer and precancer screening: 2. developing a model of population screening. Community Dent Health 1997; 14(4): 227-32.

Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48(11): 3282-7.

IARC WHO. World cancer report. Geneva: Stewar BW; 2002.

Patton LL. The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer. Oral Oncol 2003; 39(7): 708-23. http://dx.doi.org/10.1016/S1368-8375(03)00083-6

Downer MC, Moles DR, Palmer S, Speight PM. A systematic review of test performance in screening for oral cancer and precancer. Oral Oncol 2004; 40(3): 264-73. http://dx.doi.org/10.1016/j.oraloncology.2003.08.013

Whited JD, Grichnik JM. The rational clinical examination. does this patient have a mole or a melanoma? JAMA 1998; 279(9): 696-701. http://dx.doi.org/10.1001/jama.279.9.696

Burzynski NJ, Firriolo FJ, Butters JM, Sorrell CL. Evaluation of oral cancer screening. J Cancer Educ 1997 Summer; 12(2): 95-9.

Thomson PJ. Field change and oral cancer: New evidence for widespread carcinogenesis? Int J Oral Maxillofac Surg 2002; 31(3): 262-6. http://dx.doi.org/10.1054/ijom.2002.0220

Loiudice L, Abbiati R, Boselli F, Cecchini G, Costa S, Grossi E, et al. Improvement of pap smear sensitivity using a visual adjunctive procedure: A co-operative Italian study on speculoscopy (GISPE). Eur J Cancer Prev 1998; 7(4): 295-304. http://dx.doi.org/10.1097/00008469-199808000-00005

Farah CS, McCullough MJ. A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite) in the visualisation of oral mucosal white lesions. Oral Oncol 2007; 43(8): 820-4. http://dx.doi.org/10.1016/j.oraloncology.2006.10.005

Ram S, Siar CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 2005; 34(5): 521-7. http://dx.doi.org/10.1016/j.ijom.2004.10.008

Sciubba JJ. Oral cancer and its detection. history-taking and the diagnostic phase of management. J Am Dent Assoc 2001; 132(Suppl): 12S-8S.

Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg 2007; 65(3): 424-6. http://dx.doi.org/10.1016/j.joms.2006.10.055

Epstein JB, Gorsky M, Lonky S, Silverman S Jr, Epstein JD, Bride M. The efficacy of oral lumenoscopy (ViziLite) in visualizing oral mucosal lesions. Spec Care Dentist 2006; 26(4): 171-4. http://dx.doi.org/10.1111/j.1754-4505.2006.tb01720.x

Epstein JB, Silverman S,Jr, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol 2008; 44(6): 538-44. http://dx.doi.org/10.1016/j.oraloncology.2007.08.011

Huber MA, Bsoul SA, Terezhalmy GT. Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: A pilot study. Quintessence Int 2004; 35(5): 378-84.

Kerr AR, Sirois DA, Epstein JB. Clinical evaluation of chemiluminescent lighting: An adjunct for oral mucosal examinations. J Clin Dent 2006; 17(3): 59-63.

Mehrotra R, Singh M, Thomas S, Nair P, Pandya S, Nigam NS, et al. A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J Am Dent Assoc 2010; 141(2): 151-6.

Awan K, Morgan P, Warnakulasuriya S. Utility of chemiluminescence (Vizi Lite ™) in the detection of oral potentially malignant disorders and benign keratoses. J Oral Pathol Med 2011; 40: 541-544. http://dx.doi.org/10.1111/j.1600-0714.2011.01048.x

Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol 2009; 1(1): 5. http://dx.doi.org/10.1186/1758-3284-1-5

Landys J, Koch G. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74. http://dx.doi.org/10.2307/2529310

Downloads

Published

2013-08-28

Issue

Vol. 2 No. 3 (2013)

Section

Articles

How to Cite

Efficacy of Chemiluminescence (ViziLite™) as a Screening Method in the Detection of Clinically Suspicious Oral Cancerous and Precancerous Lesions. (2013). Journal of Analytical Oncology, 2(3),  176-181. https://doi.org/10.6000/1927-7229.2013.02.03.8

Similar Articles

161-170 of 186

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)